Credit Agricole’s Royalty Pharma RPRX Stock Holding History

Credit Agricole’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8M	Buy	142,595 +664	+0.5%	+$34.6K	0.02%	553
2026 Q1	$6.81M	Buy	141,931 +237	+0.2%	+$10.4K	0.02%	497
2025 Q4	$5.48M	Sell	141,694 -3,627	-2%	-$138K	0.01%	578
2025 Q3	$5.13M	Buy	+145,321	New	+$5.26M	0.01%	554
2025 Q1	$3.9M	Buy	125,130 +118,184	+1,701%	+$3.75M	0.01%	585
2024 Q4	$177K	Buy	6,946 +3,946	+132%	+$105K	﹤0.01%	1132
2024 Q3	$84.9K	Sell	3,000 -30,000	-91%	-$831K	﹤0.01%	1125
2024 Q2	$870K	Buy	+33,000	New	+$915K	﹤0.01%	755
2022 Q1	–	Sell	-1,000	Closed	-$40K	–	755
2021 Q4	$40K	Hold	1,000	–	–	﹤0.01%	548
2021 Q3	$36K	Buy	+1,000	New	+$38.9K	﹤0.01%	527

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Agricole's RPRX Position: Q2 2026 in Review

Credit Agricole increased its Royalty Pharma (RPRX) stake by 0.47% in Q2 2026, buying an estimated $34.6K and bringing the position to 142,595 shares worth $8M. The position accounts for 0.02% of the portfolio, ranked #553.

Credit Agricole first reported a position in RPRX in Q3 2021 and has held it in 10 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Credit Agricole held 142,595 shares of Royalty Pharma worth $8M as of Q2 2026.
Credit Agricole bought 664 Royalty Pharma shares in Q2 2026, an estimated $34.6K.
Royalty Pharma made up 0.02% of Credit Agricole's portfolio in Q2 2026, its #553 holding.
Credit Agricole first reported a position in Royalty Pharma in Q3 2021 and has held it in 10 quarters since.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.